Clevidipino como antihipertensivo en la cirugía de feocromocitoma
| Autor: | C. Luis-García, E. Arbonés-Aran, L. Lorente-Poch, L. Trillo-Urrutia, C. Teixell-Aleu |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Insufflation
medicine.medical_specialty business.industry Antagonist 030209 endocrinology & metabolism Vasodilation Critical Care and Intensive Care Medicine medicine.disease Surgery Pheochromocytoma 03 medical and health sciences 0302 clinical medicine Anesthesiology and Pain Medicine Pneumoperitoneum 030202 anesthesiology Anesthesia medicine Catecholamine business Perfusion Clevidipine medicine.drug |
| Zdroj: | Revista Española de Anestesiología y Reanimación. 65:225-228 |
| ISSN: | 0034-9356 |
| Popis: | Pheochromocytoma is a catecholamine-producing tumour and laparoscopic adrenalectomy is its treatment of choice. During pneumoperitoneum insufflation and tumour handling there is a high risk of massive catecholamine release and hypertensive crisis. After tumour excision, severe arterial hypotension is a common effect, due to relative vasodilation and the residual effect of antihypertensive drugs. We report the case of a patient with pheochromocytoma who was treated with laparoscopic adrenalectomy. During surgical manipulation there was a sudden hypertensive peak that could be controlled quickly with clevidipine infusion. After tumour resection, clevidipine perfusion was stopped and there were no arterial hypotension episodes. Clevidipine is a new intravenous calcium antagonist with rapid onset of action and short half-life that has no residual effect and does not produce arterial hypotension after tumour resection. For these reasons, it can be a first-choice drug for this kind of surgery. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|